Stay updated on Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.

Latest updates to the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page
- Check4 days agoChange DetectedRevision line updated from v3.6.3 to v3.6.4, indicating a newer version in the page's revision history.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision tag was updated to v3.6.3, replacing the previous v3.6.0 tag to reflect a newer version.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page adds a recruitment-status notice and new user guidance sections, along with a UI revision note indicating the version change.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page revision label was updated to v3.5.5, replacing the previous v3.5.4. This indicates a version update of the page content rather than changes to the study details.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page's revision tag has been updated to v3.5.4, replacing the previous v3.5.3. This reflects a small, non-content-related update to the page version.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page shows a new Revision: v3.5.3, replacing the previous Revision: v3.5.2, indicating a content update.SummaryDifference0.0%

Stay in the know with updates to Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Deucravacitinib Safety/Efficacy in Psoriasis Clinical Trial page.